Gemstone Biotherapeutics is a pre-clinical research and development initiative.
Gemstone Biotherapeutics is a pre-clinical research and development initiative based in Baltimore, Maryland. Gemstone is dedicated to the field of regenerative medicine and specializes in developing improved methods for advanced wound healing and tissue vascularization using licensed technology from Johns Hopkins University. Their core technologies include innovative polymeric hydrogels and stem cell engineering methodologies.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 3, 2018 | Grant | $225K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |